Find the Perfect Plan for Your Investment Journey
D
Latest price
52 Week Range
R$1.60 - R$5.29
Next Earnings Date
May 13 2025
Next Earnings Date
May 13 2025
Latest price
Market Cap | R$2.22B |
EV | R$13.72B |
Shares Outstanding | 1.25B |
Beta | 0.60 |
Analyst Rating | HOLD |
Analyst Target Price | R$4.26 |
P/E 2025E | 36.38x |
P/Revenue 2025E | 0.13x |
Revenue | 13.70% |
EPS | -99.30% |
Operating Cash Flow | -72.20% |
Free Cash Flow | - |
Revenue | 7.60% |
EPS | - |
Operating Cash Flow | 250.90% |
Free Cash Flow | - |
Gross Margin 2025E | 30.00% |
Net Profit Margin 2025E | -0.85% |
ROE 2025E | -3.98% |
ROCE 2024 | -15.72% |
DPS 2025E | R$0.00 |
Payout Ratio 2025E | 0.00% |
Div. Yield 2025E | 0.00% |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
D
Diagnósticos da América S.A.
DASA3
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Cintra, Licio Tavares
Employees
18,142
Website
www.dasa3.com.brIPO Date
2004-11-19
Headquarters
Avenida Juruá, nº 434, Alphaville, Barueri, São Paulo, 06455-010, Brazil
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved